Skip to content
Riskpilot
← Back to search
Sign in
Get full access
BELLEVACC AS
AS
Active
Org 914753538
Høgskoleveien 8, 1433
Ås
Manufacture of pharmaceutical preparations
·
NACE 2120
Est. 2015 · 11 years old
0 employees
Monitor
Share
Norway
/
Companies
/
Manufacture of pharmaceutical preparations
/
BELLEVACC AS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Former (1)
TL
Terje Landsgård
Contact Person
Contact Person
2020 – 2020
Board of directors
Non-executive oversight
Name
Role
Member since
Current (3)
RH
Rune Henning Sørum
Board of Directors
Board of Directors
2018
LK
Lars Kristian Bredahl
Board of Directors
Board of Directors
2025
AK
Aud Kari Fauske
Chairman
Chairman
2025
Former (5)
NH
Nils Haga
Chairman
Chairman
2018 – 2023
KS
Kira Salonius
Board of Directors
Board of Directors
2023 – 2024
ML
Mathias Lange Dokkan-Thorsen
Board of Directors
Board of Directors
2024 – 2025
HP
Hallvard Peter Bogh Muri
Chairman
Chairman
2024 – 2025
HT
Hege Tjørsvaag Brattebø
Chairman
Chairman
2023 – 2024
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
Previwo As
Company
75.86%
75.86%
2025
Henning Sørum Holding As
Company
24.14%
24.14%
2025
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on BELLEVACC AS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network